Sweden's Midsona Q3 net sales rise, gross margin improves

By Reuters News


Overview

  • Sweden health products firm's Q3 net sales rose 1.7% yr/yr, organic sales declined

  • Gross margin improved to 29.0% from 23.1% a year earlier

  • CEO cites higher costs, heatwave, and slow strategy execution as factors impacting results


Outlook

  • Midsona did not provide specific financial guidance for the current or coming periods in its press release


Result Drivers

  • PRODUCT MIX - CEO said profitability improved mainly due to product mix

  • RETAILER DELISTINGS - CEO said sales in North Europe were hampered by retailer delistings, especially of own brands

  • BRAND PERFORMANCE - CEO said brands with clear positioning and product development, such as Friggs, Helios, Kung Markatta and Risenta, performed well


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

SEK 910 mln

Q3 Adjusted Free Cash Flow

SEK 57 mln


Analyst Coverage

  • The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Oct 22 - Sweden's Axfood Q3 EBIT beats on volume growth

  • Oct 22 - Sweden's Essity slightly misses Q3 net sales estimates

  • Oct 22 - Fiskars Q3 comparable net sales rise on volume growth


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk